1. Pink Sheet

Could The US FDA Set Clinical Trial Diversity Minimums?

 
• By Derrick Gingery

Oncology Center of Excellence Director Richard Pazdur asked whether the FDA should have more conversations with sponsors about site selection and percentages of US participants.

Cancer clinical trial diversity panel discussion
FDA, industry and patient advocates discussed clinical trial diversity issues during a 4 May Cancer Moonshot community conversation. • Source: Screenshot

Clinical trial diversity requirements for US drug approval soon could include a mandatory minimum domestic trial enrollment or at least a justification of trial site selection.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D